These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6176796)

  • 21. Effect of bopindolol on the circadian blood pressure profile in essential hypertension.
    Favre L; Adamec R; Boxho G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S60-3. PubMed ID: 2439823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New design for clinical trial of antihypertensive drugs applied to pindolol, clopamide, and combinations thereof.
    Nyberg G; Asplund J; Anagreus N; Aström B; Leppert J; Bergström R; Overmo J; Kullman S; Lessem J
    Lancet; 1982 Feb; 1(8268):355-8. PubMed ID: 6120347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihypertensive effect of bopindolol: a multi-centre study.
    Török E; Szám I; Buday G; Kerkovits G; Farsang C; Hajtman B
    J Hum Hypertens; 1990 Aug; 4(4):458-60. PubMed ID: 1979635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect on blood pressure of beta-adrenoreceptor-blocking drugs given once daily.
    Wilson M; Morgan G; Morgan T
    Clin Sci Mol Med Suppl; 1976 Dec; 3():527s-528s. PubMed ID: 1071674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A dose-finding study of the combination of pindolol, clopamide and endralazine in the treatment of moderate-to-severe hypertension.
    Seedat YK; Rawat R
    S Afr Med J; 1984 Nov; 66(18):682-4. PubMed ID: 6387966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative effects of pindolol and atenolol on blood pressure and lipids in mild to moderate arterial hypertension].
    Herpin D; Guillard O; Piriou A; Amiel A; Boutaud P; Ciber MA; Demange J
    Ann Med Interne (Paris); 1988; 139(7):484-7. PubMed ID: 3072894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of pindolol and methyldopa on blood pressure and plasma norepinephrine.
    Winer N; Carter CH; Eddy H
    Am Heart J; 1982 Aug; 104(2 Pt 2):425-31. PubMed ID: 7048879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship of plasma levels of pindolol in hypertensive patients to effects on blood pressure, plasma renin and plasma noradrenaline levels.
    Anavekar SN; Louis WJ; Morgan TO; Doyle AE; Johnston CI
    Clin Exp Pharmacol Physiol; 1975; 2(3):203-12. PubMed ID: 1149326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pharmacodynamic and pharmacokinetic comparison of pindolol 20 mg retard and a conventional tablet.
    Aellig WH; Narjes HH; Nüesch E; Oertle RJ; Devos JE; Pacha W
    Eur J Clin Pharmacol; 1981; 20(3):179-83. PubMed ID: 7286035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of pindolol dosage in hypertension by automatic indirect BP monitoring.
    Sheps SG; Schirger A; Spiekerman RE; Harman TR; O'Brien PC; Kleven MK; Kremer-Simpson K
    Arch Intern Med; 1985 Jan; 145(1):54-7. PubMed ID: 3970647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-finding study with bopindolol in arterial hypertension.
    Willimann P; Peter R; Siegenthaler H
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S25-9. PubMed ID: 2439814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pindolol: effects on blood pressure and plasma renin activity.
    Glassock RJ; Weitzman RE; Bennett CM; Maxwell M; Hamilton B; Winer N; Kirkendall W; Gonasun L
    Am Heart J; 1982 Aug; 104(2 Pt 2):421-5. PubMed ID: 7048878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihypertensive treatment with pindolol in one or two doses. A comparative trial.
    Gyntelberg F; Rasmussen K; Harvald B
    Acta Med Scand; 1978; 204(3):169-71. PubMed ID: 358760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antihypertensive action of various talinolol dosages after four week's treatment in comparison with placebo].
    Weigmann I; Terhaag B; Wierich W; Herrmann WM
    Arzneimittelforschung; 1998 Mar; 48(3):240-4. PubMed ID: 9553680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive effects of pindolol.
    Gonasun LM
    Am Heart J; 1982 Aug; 104(2 Pt 2):374-87. PubMed ID: 7048877
    [No Abstract]   [Full Text] [Related]  

  • 36. Endralazine, a new peripheral vasodilator: absence of effect of acetylator status on antihypertensive effect.
    Holmes DG; Bogers WA; Wideroe TE; Huunan-Seppala A; Wideroe B
    Lancet; 1983 Mar; 1(8326 Pt 1):670-1. PubMed ID: 6132036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical experience with a once-daily, extended-release formulation of diltiazem in the treatment of hypertension.
    Graney WF
    Am J Med; 1992 Aug; 93(2A):56S-64S. PubMed ID: 1519637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a beta-adrenoceptor antagonist, pindolol, on human uterine smooth muscle.
    Ingemarsson I; Adaikan PG; Arulkumaran S; Kottegoda SR
    Gynecol Obstet Invest; 1987; 24(3):185-9. PubMed ID: 3692331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamics of metoprolol and pindolol in systemic hypertension with particular reference to reversal of structural vascular changes.
    Hansson L
    Am J Cardiol; 1986 Feb; 57(5):29C-32C. PubMed ID: 3946248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary function in hypertensive patients treated with pindolol: a report of two studies.
    Hamilton BP; Hamilton J; Kirkendall WM
    Am Heart J; 1982 Aug; 104(2 Pt 2):432-7. PubMed ID: 7048880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.